1. Correction to: Potentiating CD8+ T cell antitumor activity by inhibiting PCSK9 to promote LDLR-mediated TCR recycling and signaling. Issue 9 (7th September 2021) Authors: Yuan, Juanjuan; Cai, Ting; Zheng, Xiaojun; Ren, Yangzi; Qi, Jingwen; Lu, Xiaofei; Chen, Huihui; Lin, Huizhen; Chen, Zijie; Liu, Mengnan; He, Shangwen; Chen, Qijun; Feng, Siyang; Wu, Yingjun; Zhang, Zhenhai; Ding, Yanqing; Yang, Wei Journal: Protein & cell Issue: Volume 13:Issue 9(2022) Page Start: 694 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Potentiating CD8+ T cell antitumor activity by inhibiting PCSK9 to promote LDLR-mediated TCR recycling and signaling. Issue 4 (19th February 2021) Authors: Yuan, Juanjuan; Cai, Ting; Zheng, Xiaojun; Ren, Yangzi; Qi, Jingwen; Lu, Xiaofei; Chen, Huihui; Lin, Huizhen; Chen, Zijie; Liu, Mengnan; He, Shangwen; Chen, Qijun; Feng, Siyang; Wu, Yingjun; Zhang, Zhenhai; Ding, Yanqing; Yang, Wei Journal: Protein & cell Issue: Volume 12:Issue 4(2021) Page Start: 240 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗